BDBM46871 MLS000547894::N-(2,5-dimethoxyphenyl)-3,4-dimethoxy-N-(2-oxidanylidene-2-piperidin-1-yl-ethyl)benzenesulfonamide::N-(2,5-dimethoxyphenyl)-3,4-dimethoxy-N-(2-oxo-2-piperidin-1-ylethyl)benzenesulfonamide::N-(2,5-dimethoxyphenyl)-3,4-dimethoxy-N-[2-oxo-2-(1-piperidinyl)ethyl]benzenesulfonamide::N-(2,5-dimethoxyphenyl)-N-(2-keto-2-piperidino-ethyl)-3,4-dimethoxy-benzenesulfonamide::SMR000113666::cid_982506

SMILES NC(=O)[C@H]1CC[C@H](Nc2ncc(F)c(-c3cccc(C4(O)COC4)c3)n2)CC1

InChI Key InChIKey=JUQPFSJPDWUZFC-UHFFFAOYSA-N

Data  2 EC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 46871   

TargetPhosphatidylinositol 5-phosphate 4-kinase type-2 gamma(Human)
c/o Larkspur Biosciences, Inc.

WIPO
LigandChemical structure of BindingDB Monomer ID 46871BDBM46871(trans-4-((5-fluoro-4-(3-(3-hydroxyoxetan-3-yl)phen...)
Affinity DataKd: <500nMAssay Description:Source (MLSCN Center Name): The Scripps Research Institute Molecular Screening Center Affiliation: The Scripps Research Institute, TSRI Assay Provide...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/24/2026
Entry Details US Patent